NEU:ASX
Neuren Pharmaceuticals Ltd
A$20.43
arrow_upward
+0.74%(+0.15) 1D
Oct 5, 4:10:07 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEU...
Open
A$20.30
High
A$20.63
Low
A$19.98
Mkt. cap
2.59B
Avg. vol.
448.30K
Volume
210.92K
Dividend
0.73%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
132.34
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
Open
A$20.30
High
A$20.63
Low
A$19.98
Mkt. cap
2.59B
Avg. vol.
448.30K
Volume
210.92K
Dividend
0.73%
Quarterly dividend
A$0.04
Ex-dividend date
Sep 15, 2026
P/E ratio
132.34
52-wk high
A$23.76
52-wk low
A$11.00
EPS
A$0.15
Shares outstanding
126.77M
No. of employees
8
News stories
From web sources and news partners
Simply Wall Street
·
37 minutes ago
AI Chips Update - AIBotics Boosts AI Strategy with Empulser Acquisition
The Daily News | Texas' Oldest Newspaper
·
55 minutes ago
NYSE logo in New York City
The Quantum Insider
·
16 minutes ago
WISeSat.Space Completes Business Combination and Begins Nasdaq Trading
Yahoo Finance
·
53 minutes ago
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About Neuren Pharmaceuticals Ltd
CEOJon Pilcher
Employees8
Founded2001
Headquarters-
SectorPharmaceutical industry
Websiteneurenpharma.com